NOP58 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.281600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.099000E-01
Normal-vs-Stage2
7.002000E-01
Normal-vs-Stage3
6.389800E-01
Normal-vs-Stage4
1.983430E-01
Stage1-vs-Stage2
9.389000E-01
Stage1-vs-Stage3
3.485000E-01
Stage1-vs-Stage4
2.159400E-01
Stage2-vs-Stage3
2.903000E-01
Stage2-vs-Stage4
8.400400E-02
Stage3-vs-Stage4
6.772400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.045800E-01
Normal-vs-AfricanAmerican
8.981400E-01
Normal-vs-Asian
5.885400E-01
Caucasian-vs-AfricanAmerican
4.896600E-01
Caucasian-vs-Asian
9.465000E-01
AfricanAmerican-vs-Asian
3.373200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.758600E-01
Normal-vs-Female
7.659600E-01
Male-vs-Female
9.775400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.265200E-01
Normal-vs-Age(41-60Yrs)
5.655800E-01
Normal-vs-Age(61-80Yrs)
7.978200E-01
Normal-vs-Age(81-100Yrs)
4.489000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.358000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.809800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.268810E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.430000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.899400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.405800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.726000E-01
Normal-vs-Daily Drinker
8.716400E-01
Normal-vs-Weekly Drinker
6.150400E-01
Normal-vs-Occasional Drinker
5.721600E-01
Normal-vs-Social Drinker
9.211600E-01
Non Drinker-vs-Daily Drinker
7.892600E-01
Non Drinker-vs-Weekly Drinker
2.972600E-01
Non Drinker-vs-Occasional Drinker
3.588600E-01
Non Drinker-vs-Social Drinker
7.943600E-01
Daily Drinker-vs-Weekly Drinker
3.488000E-01
Daily Drinker-vs-Occasional Drinker
5.129800E-01
Daily Drinker-vs-Social Drinker
6.191000E-01
Weekly Drinker-vs-Occasional Drinker
4.842400E-01
Weekly Drinker-vs-Social Drinker
2.555200E-01
Occasional Drinker-vs-Social Drinker
1.852990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.120600E-01
Normal-vs-Grade 2
1.568020E-01
Normal-vs-Grade 3
6.833800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.323870E-02
Grade 1-vs-Grade 3
3.644300E-03
Grade 1-vs-Grade 4
4.120600E-01
Grade 2-vs-Grade 3
7.154400E-01
Grade 2-vs-Grade 4
1.568020E-01
Grade 3-vs-Grade 4
6.833800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.871200E-01
Normal-vs-NonDiabetic
7.778800E-01
Diabetic-vs-NonDiabetic
5.070200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.142600E-01
Normal-vs-NoPancreatitis
8.156600E-01
Pancreatitis-vs-NoPancreatitis
4.889800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.162400E-01
Normal-vs-N1
7.385800E-01
N0-vs-N1
7.721800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.669400E-01
Normal-vs-TP53-NonMutant
7.720000E-01
TP53-Mutant-vs-TP53-NonMutant
4.622800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
